NCT05736094Completed
Ultrasound for Detection of Prostate Cancer
Dual-frequency Ultrasound for Detection of Prostate Cancer
Source: ClinicalTrials.gov · Last updated 5 Apr 2024
Brief summary (registry, in English)
Clinical proof of concept of dual-frequency ultrasound imaging for detection and visualization of prostate cancer.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 11 (actual)
- First submitted
- 10 Feb 2023
- Start date
- 14 Feb 2023
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Oslo University Hospital
- Diseases
- Prostate cancer
- NCT number
- NCT05736094
What you commit to
- Study type: Interventional
- Participants enrolled: 11
- From 14 Feb 2023 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- N/A
Who the study is looking for
- Age 18 years onwards
- Signed written informed consent to perform rectal and transperineal ultrasound
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Oslo University Hospital Coordinator of this site? Confirm its status | Oslo | Norway | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.